Moderna launches phase 3 vaccine trial in 30,000 Americans at 89 sites
Read full article: Moderna launches phase 3 vaccine trial in 30,000 Americans at 89 sitesOne of those is known as the Moderna vaccine. Dawn Baker was the first phase three volunteer to receive the Moderna vaccine Monday morning in Savannah, Georgia. Shes one of 30,000 Americans expected to take part in the trial at 89 locations across the country. The Moderna vaccine is a messenger RNA vaccine. Phase three is the pivotal phase to demonstrate the safety and efficacy of any drug.